These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38082499)

  • 1. Persistent pruritus associated with worse quality of life in patients with chronic hepatitis.
    Lu M; Rupp LB; Melkonian C; Trudeau S; Daida YG; Schmidt MA; Gordon SC
    Liver Int; 2024 Feb; 44(2):577-588. PubMed ID: 38082499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication.
    Younossi ZM; Stepanova M; Younossi I; Papatheodoridis G; Janssen HLA; Agarwal K; Nguyen MH; Gane E; Tsai N; Nader F
    Liver Int; 2019 Oct; 39(10):1837-1844. PubMed ID: 31173468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES.
    Butt AA; Yan P; Aslam S; Sherman KE; Siraj D; Safdar N; Hameed B
    Int J Infect Dis; 2020 Mar; 92():184-188. PubMed ID: 31978574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
    Yeh ML; Hung CH; Tseng KC; Lai HC; Chen CY; Kuo HT; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Tai CM; Lin CW; Kao JH; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Huang CF; Huang JF; Dai CY; Chuang WL; Tsai PC; Peng CY; Liu CJ; Yu ML
    Hepatol Int; 2021 Oct; 15(5):1109-1121. PubMed ID: 34365587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infection with hepatitis B does not alter treatment response in chronic hepatitis C.
    Uyanikoglu A; Akyuz F; Baran B; Simsek BP; Ermis F; Demir K; Gulluoglu M; Badur S; Kaymakoglu S
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):485-90. PubMed ID: 23665172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204.
    Hwang JP; Arnold KB; Unger JM; Chugh R; Tincopa MA; Loomba R; Hershman D; Ramsey SD
    Support Care Cancer; 2022 Dec; 31(1):93. PubMed ID: 36585488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free.
    Fagundes RN; Ferreira LEVVC; Pace FHL
    PLoS One; 2020; 15(8):e0237005. PubMed ID: 32813740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection].
    Garbuzenko DV
    Vopr Virusol; 2021 Nov; 66(5):331-339. PubMed ID: 34738448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world effect of ribavirin on quality of life in HCV-infected patients receiving interferon-free treatment.
    Höner Zu Siederdissen C; Schlevogt B; Solbach P; Port K; Cornberg M; Manns MP; Wedemeyer H; Deterding K
    Liver Int; 2018 May; 38(5):834-841. PubMed ID: 28960793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis: A Secondary Analysis of a Randomized Clinical Trial.
    Kimel M; Zeidler C; Kwon P; Revicki D; Ständer S
    JAMA Dermatol; 2020 Dec; 156(12):1354-1358. PubMed ID: 32936233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pruritus and the hepatitis C virus. The MULTIVIRC Unit].
    Dega H; Francès C; Dupin N; Lebre C; Simantov A; Callot C; Laporte JL; Blot C; Opolon P; Poynard T; Chosidow O
    Ann Dermatol Venereol; 1998 Jan; 125(1):9-12. PubMed ID: 9747198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Hepatitis B Virus Reactivation Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection.
    Yanny BT; Latt NL; Saab S; Han S; Choi G; Kramer J; Sahota AK
    J Clin Gastroenterol; 2018; 52(10):908-912. PubMed ID: 29334502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
    Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
    J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care quality and outcomes among US veterans with chronic hepatitis B in the hepatitis C direct-acting antiviral era.
    Kaplan DE; Medvedeva E; Serper M
    J Viral Hepat; 2020 Oct; 27(10):1082-1092. PubMed ID: 32484991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive ability of shear wave elastography for pruritus in chronic hepatitis C patients with sustained virological response.
    Tachi Y; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H; Katano Y
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1066-1072. PubMed ID: 29727381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.
    Yeh ML; Huang CF; Huang CI; Holmes JA; Hsieh MH; Tsai YS; Liang PC; Tsai PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Chung RT; Yu ML
    J Hepatol; 2020 Jul; 73(1):62-71. PubMed ID: 32061869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection.
    Coppola N; Stanzione M; Messina V; Pisaturo M; De Pascalis S; Macera M; Tonziello G; Fiore M; Sagnelli C; Pasquale G; Sagnelli E
    J Viral Hepat; 2012 Dec; 19(12):890-6. PubMed ID: 23121368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of unhealthy behaviors, the prevalence and receipt of antiviral treatment for disabled adult hepatitis B and C carriers.
    Jane SW; Lin MS; Chiu WN; Lai LJ; Chen PH; Chen MY
    BMC Public Health; 2016 Feb; 16():146. PubMed ID: 26873327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.